0000899243-17-023972.txt : 20171010 0000899243-17-023972.hdr.sgml : 20171010 20171010195702 ACCESSION NUMBER: 0000899243-17-023972 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171006 FILED AS OF DATE: 20171010 DATE AS OF CHANGE: 20171010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Louks Ronald Allen CENTRAL INDEX KEY: 0001706849 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37792 FILM NUMBER: 171131635 MAIL ADDRESS: STREET 1: C/O NANTHEALTH, INC. STREET 2: 9920 JEFFERSON BLVD. CITY: CULVER CITY STATE: CA ZIP: 90232 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NantHealth, Inc. CENTRAL INDEX KEY: 0001566469 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 273019889 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9920 JEFFERSON BLVD CITY: CULVER CITY STATE: CA ZIP: 90232 BUSINESS PHONE: (310) 853-7888 MAIL ADDRESS: STREET 1: 9920 JEFFERSON BLVD CITY: CULVER CITY STATE: CA ZIP: 90232 FORMER COMPANY: FORMER CONFORMED NAME: Nant Health, LLC DATE OF NAME CHANGE: 20130108 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-10-06 0 0001566469 NantHealth, Inc. NH 0001706849 Louks Ronald Allen C/O NANTHEALTH, INC. 9920 JEFFERSON BLVD. CULVER CITY CA 90232 0 1 0 0 Chief Operating Officer Common Stock 2017-10-06 4 M 0 40000 A 40000 D Common Stock 2017-10-06 4 F 0 13180 4.28 D 26820 D Common Stock 2017-10-06 4 S 0 26820 4.28 D 0 D Restricted Stock Units 2017-10-06 4 M 0 40000 0.00 D Common Stock 40000 120000 D Each restricted stock unit ("RSU") is the economic equivalent of one share of NantHealth, Inc. common stock. Subject to the Reporting Person's continuing to be a service provider (as defined in the 2016 Equity Incentive Plan) through each applicable vesting date, 40,000 RSUs shall vest on October 6, 2017, with the remaining 120,000 RSUs to vest monthly in equal amounts for 12 months, beginning on November 6, 2017. Upon vesting, the issuer will withhold shares sufficient to satisfy tax withholding obligations; the issuer will then be responsible for remitting a cash payment for the related withholding taxes; and the issuer will issue to the Reporting Person a net lower number of shares. In addition, upon vesting, the issuer and the Reporting Person have agreed that the issuer will repurchase the remaining shares at the then current market value. Pursuant to the terms of the grant, the Issuer repurchased the shares at a price per share equal to the closing price on the date of vesting /s/ Charles Kim, as Attorney-in-Fact 2017-10-10